Publications & Intellectual Property

Strategic dissemination in a research driven company

Perfect Lens is a research and development focused company operating in a highly competitive and regulated space. While scientific publications play an important role in knowledge exchange, unrestricted disclosure is not always compatible with protecting first in class technologies.

As a result, publication activity is selective and strategic. Early findings are often shared through invited talks, conference presentations, and closed expert discussions, while core innovations are protected through patents prior to broader disclosure.

This approach allows continued investment in long term research programs while maintaining freedom to operate across both manufacturing and investigational in vivo applications.

StrategicPublishing R&DFocused IPFirst

60+ patents worldwide

Granted patents and active applications covering core RIS processes, system architectures, and clinical workflows.

In vivo & manufacturing

Intellectual property spans both post implant refractive adjustment and manufacturing customization use cases.

Right to use

Perfect Lens maintains detailed internal right to use analyses supporting freedom to operate across key markets.

Patent counts are provided as approximate values. Public patent databases do not always reflect the most current filing status.

External references

Company updates on LinkedIn

Selected updates, conference participation, and company milestones are shared through our official LinkedIn presence.

Visit Perfect Lens on LinkedIn

Public patent records

An overview of published patent filings associated with Perfect Lens is available through public patent databases.

View patents on Justia

Note: Public patent listings may not reflect the most recent filings, prosecution status, or internal portfolio structure.